News
Eli Lilly and Company and the UK Government have announced a joint programme to develop innovative models of care for obesity ...
Eli Lilly and Company has announced positive topline results from its phase 3 BRUIN CLL-314 trial of Jaypirca (pirtobrutinib) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback